SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia Genetic Test
At DNA Labs UAE, we offer the SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia Genetic Test at a cost of AED 4400.0.
Test Details:
The SLC2A1 gene is associated with a condition called paroxysmal exercise-induced dyskinesia (PED) with epilepsy and/or hemolytic anemia. This condition is characterized by episodes of abnormal involuntary movements (dyskinesia) triggered by exercise or physical exertion. These episodes may involve the limbs, face, or trunk and can vary in severity and duration.
In addition to dyskinesia, individuals with PED may also experience seizures (epilepsy) and/or hemolytic anemia. Epileptic seizures can manifest as generalized tonic-clonic seizures, absence seizures, or other types of seizures. Hemolytic anemia is a condition characterized by the destruction of red blood cells, leading to a reduced ability of the blood to carry oxygen.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variants that may be associated with a particular condition. In the case of PED with epilepsy and/or hemolytic anemia, NGS genetic testing can be used to identify mutations or variants in the SLC2A1 gene that may be responsible for the condition.
By identifying the specific genetic variant causing PED with epilepsy and/or hemolytic anemia, NGS genetic testing can help in the diagnosis and management of affected individuals. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.
Test Components and Price:
- Test Name: SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia Genetic Test
- Price: AED 4400.0
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia.
Test Name | SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy andor hemolytic anemia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia |
Test Details |
The SLC2A1 gene is associated with a condition called paroxysmal exercise-induced dyskinesia (PED) with epilepsy and/or hemolytic anemia. This condition is characterized by episodes of abnormal involuntary movements (dyskinesia) triggered by exercise or physical exertion. These episodes may involve the limbs, face, or trunk and can vary in severity and duration. In addition to dyskinesia, individuals with PED may also experience seizures (epilepsy) and/or hemolytic anemia. Epileptic seizures can manifest as generalized tonic-clonic seizures, absence seizures, or other types of seizures. Hemolytic anemia is a condition characterized by the destruction of red blood cells, leading to a reduced ability of the blood to carry oxygen. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variants that may be associated with a particular condition. In the case of PED with epilepsy and/or hemolytic anemia, NGS genetic testing can be used to identify mutations or variants in the SLC2A1 gene that may be responsible for the condition. By identifying the specific genetic variant causing PED with epilepsy and/or hemolytic anemia, NGS genetic testing can help in the diagnosis and management of affected individuals. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling. |